Signaling
[대역어] None
[용어속성] Term
[용어속성] Term
Mechanisms of host type I interferon response modulation by the nucleocapsid proteins of alpha- and betacoronaviruses
알파 및 베타 코로나바이러스의 뉴클레오캡시드 단백질에 의한 숙주 유형 I 인터페론 반응 조절 메커니즘
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Alpha
animals
Antiviral
antiviral responses
betacoronavirus
cause
coronavirus
Coronavirus infections
COVID-19 pandemic
Critical
diarrhea
epidemic diarrhea
facilitate
Fatality rate
function
genomic RNA
Health
Host
Human
humans
initial
innate immune response
involved
knowledge
modulate
modulation
Neonatal
nucleocapsid protein
Nucleocapsid proteins
PEDV
Replication
responses
responsible
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
shown
Signaling
type I interferon
viral genomic RNA
Viral RNA
virions
virus
Virus-host interactions
[DOI] 10.1007/s00705-022-05513-8 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s00705-022-05513-8 PMC 바로가기 [Article Type] Review
Recent clinical findings on the role of kinase inhibitors in COVID-19 management
COVID-19 관리에서 키나제 억제제의 역할에 대한 최근 임상 결과
Review
[키워드] activator
affected
alleviate
Anti-inflammatory
anti-viral effects
antiviral agent
Antiviral agents
BTK
clinical evidence
Clinical finding
Clinical practice
clinical trial
Complication
complications
Consequences
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 patients
CRS
cytokine release storm
drug
Efficacy
glycogen synthase
GSK-3
highly pathogenic
inhibitor
inhibitors
JAK/STAT
janus
Janus kinase
kinase
Kinase inhibitor
kinase inhibitors
kinases
management
MAPK
Novel coronavirus
novel coronavirus disease
outbreak
p38 MAPK.
pandemic
paradigm shift
performed
pharmacological
pharmacological intervention
protein kinase
recent
Signaling
STAT
therapy
Transcription
trials
Viral load
[DOI] 10.1016/j.lfs.2022.120809 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.lfs.2022.120809 PMC 바로가기 [Article Type] Review
Friend or foe: RIG- I like receptors and diseases
Article
[키워드] Activation
anti-tumor immunity
antibody
Antiviral
antiviral immune response
Autoimmune diseases
autoinflammatory disease
Autoinflammatory diseases
Bacterial infections
cascade
disease
Diseases
Friend
genes encoding
Guidance
Host
IFNs
immunomodulatory therapy
include
involved
malaria
MDA5
mechanism
mechanisms
microRNA
miRNAs
Mutation
polymorphism
post-translational modification
proinflammatory cytokines
Proteins
recent finding
receptor
Regulatory
RIG-I
RLR
RLRs
RLRs.
RNA virus
SARS-CoV-2
Signaling
single-nucleotide
SNPs
transcriptional
type I interferon
[DOI] 10.1016/j.autrev.2022.103161 PMC 바로가기
[DOI] 10.1016/j.autrev.2022.103161 PMC 바로가기
Simultaneous Detection of RIG-1, MDA5, and IFIT-1 Expression Is a Convenient Tool for Evaluation of the Interferon-Mediated Response
Article
[키워드] A549 cell
acute phase
assumed
both virus
clinical
Course
cytosolic
cytosolic sensors
detection
disease onset
Disease progression
donors
elevated
evaluated
expression
Genes
H3N2
immune response
in vitro
in vitro transcribed RNAs
influenza A
influenza A virus
inhibit
interferon-stimulated gene
interferons
ISGs
MDA5
Mild-to-moderate
mRNA expression
mRNA level
multiple mechanism
multiplex
not differ
observation
onset of symptoms
pathogenesis of SARS-CoV-2
patients with influenza
post infection
qPCR
qPCR assay
qPCR.
remained
response
RNA
RNAs
SARS-CoV-2
SARS-CoV-2 patient
Signaling
Simultaneous
SOCS-1
the disease
transcribed
transfected with
type I
virus
White blood cell
White blood cells
worsening
[DOI] 10.3390/v14102090 PMC 바로가기
[DOI] 10.3390/v14102090 PMC 바로가기
Comparison of Intracellular Transcriptional Response of NHBE Cells to Infection with SARS-CoV-2 Washington and New York Strains
Article
Published on
Journal: Frontiers in Cellular and Infection Microbiology
[Category] SARS, 유전자 메커니즘, 치료기술,
Journal: Frontiers in Cellular and Infection Microbiology
[Category] SARS, 유전자 메커니즘, 치료기술,
[키워드] 24 hour
acute respiratory syndrome
affected
analyzed
bioinformatics
caused
Cell
cellular
coronavirus
COVID-19
D614G mutation
Data mining
death
DEGs
different time point
differentially expressed gene
dysregulated
Effect
epithelial
experiment
Gene ontology
Genome
global pandemic
GO terms
Host
host cells
host response
Host transcriptional response
host-virus
hpi
identify
immune
IMPROVE
include
Infection
infections
inhibited
Intracellular
mechanism
Mutation
New York
NHBE
pathway
Pathways
Patient
positive
Post-infection
reported
response
resulting
RNA sequencing data
SARS-CoV-2
SARS-CoV-2 isolate
severe disease
shown
Signaling
signaling pathways
similarity
stability
strain
Strains
These data
transcript
translation
viral isolate
viral spike protein
Virology.
virus
virus replication
Washington
while
Wuhan, China
[DOI] 10.3389/fcimb.2022.1009328 PMC 바로가기
[DOI] 10.3389/fcimb.2022.1009328 PMC 바로가기
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
MiRNA-SARS-CoV-2 대화 및 전향적인 항-COVID-19 치료법
Review
Published on
Journal: Life sciences
[Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제,
Journal: Life sciences
[Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
adverse effect
adverse effects
Affect
antiviral response
approach
approved
Biomarker
caused
Cell signaling
chance
Clinical significance
Comorbidities
coronavirus
Coronavirus-2
country
COVID-19
COVID-19 illness
COVID-19 infection
COVID-19 pathogenesis
COVID-19 patient
Critical
death
detect
differential expression
disease
disease onset
disease pathology
effort
etiology
expression
FDA
focus
Host
host cell
host inflammatory response
host miRNA
host miRNAs
identify
Infection
life cycle
microRNA
miRNA
miRNAs
molecular interaction
non-coding RNA
offer
pathogen
Pathogen-host interaction
patients with COVID-19
post-transcriptionally
quest
reduce
respiratory
respond
RNA
RNA silencing
SARS Coronavirus
SARS coronavirus 2
SARS coronavirus 2.
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2 virus
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severity
Signaling
target gene
the SARS-CoV-2 virus
therapy
treat
Treatment
Viral
viral miRNA
viral miRNAs
[DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
Article
[키워드] Activation
amplified
amplify
analyzed
blocked
Blood
Cell
chemokine
chronic liver disease
Chronic Liver Diseases
circulating
comorbid disease
Comorbidity
contribute
controls
correlated
COVID-19
COVID-19 patients
Critical
cytokine
cytokine secretion
DCLK1
DDCLK1
decrease
disease severity
dysregulation
expression
Factor
Factors
Gain
growth factor
hospitalized patient
Host
Hyperinflammatory response
immune
Immune cell
immune response
immunosuppressive
in viral
in vitro
infected cells
Inflammation
Inflammatory cytokine
inflammatory pathway
inhibition
inhibitor
Innate immunity
involved
kinase
Live virus
liver
livers
loss of function
lung
Lung disease
Macrophage
mononuclear cell
mononuclear cells
Mortality
neutrophil
normalized
Pathogenesis
pathology
Patient
Peripheral blood
potential therapeutic target
Prevalence
pro-inflammatory
profile
proinflammatory
promoted
promoter
Protein
S100A9
SARS-CoV-2
SARS-CoV-2-infected cell
secretion
severity of COVID-19
Signaling
subject
targeting
Treatment
Viremia
virus production
virus replication
Virus replication.
with COVID-19
β-catenin
[DOI] 10.1128/jvi.00967-22 PMC 바로가기
[DOI] 10.1128/jvi.00967-22 PMC 바로가기
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes
Article
[키워드] abundance
acute phase
acute respiratory syndrome
Alter
Analysis
approach
approach
assays
body mass index
C-reactive protein
circulating
clinical decision
Compromised
coronavirus
COVID-19
COVID-19 pathogenesis
COVID-19 patient
creatinine
criterion
Critical
Critically ill
cut-off value
determine
disease
disrupt
driven by
dysregulation
energy-related metabolites
evaluated
Extracellular
fluorometric quantification
Glucose
Health
Host
Host immune response
immune response
implicated
IMPROVE
Increased
independent predictor
Infection
Lactate
mechanisms
metabolism
metabolite
metabolomics
mitochondrial
outcome
outcomes
Patient
Potential biomarker
Prognosis
Prognostic marker
provided
pyruvate
quantification
Quantitative
recruited
risk
SARS-CoV-2
SARS-COV-2 infection
semi-targeted metebolomics.
serum
severe COVID-19 illness
severity
Signaling
Stratification
Support
validation cohort
virus
[DOI] 10.3389/fimmu.2022.912579 PMC 바로가기
[DOI] 10.3389/fimmu.2022.912579 PMC 바로가기
Transcriptomics, Cheminformatics, and Systems Pharmacology Strategies Unveil the Potential Bioactives to Combat COVID-19
Article
[키워드] addition
analysis
analyzed
approach
caused
Cheminformatics
co-expression
combat
Complete
COVID-19
determine
disease
drug candidate
Efficiency
Features
functional
Genetic
higher efficiency
identify
immune
immune gene
Infection
Laboratory
lack
mechanism
molecular
molecular docking
molecular docking analysis
Mutation
pathway enrichment
pharmacological
Pharmacology
Phytocompounds
plant
plants
Potential
Prevalence
Regulation
required
SARS-CoV-2
selected
Side effects
Signaling
Strategy
System
systems pharmacology.
the SARS-CoV-2 virus
therapeutic
these compound
transcriptomics
transmission rate
treat
unique
unique genes
Vaccinations
viral disease
[DOI] 10.3390/molecules27185955 PMC 바로가기
[DOI] 10.3390/molecules27185955 PMC 바로가기